Götterlehre oder mythologische Dichtungen

GÖTTERLEHRE ODER MYTHOLOGISCHE DICHTUNGEN Götterlehre oder mythologische Dichtungen (-) Einband (-) Jupiters Erziehung auf der Insel Kreta (-) Titelseite (-) Einleitung (-) Inhaltsverzeichnis (-) Gesichtspunkt für die mythologischen Dichtungen ([1]) Die Erzeugung der Götter (10) Der Götterkrieg (16) Abbildung: Jupiters Donnerwagen, Saturn (-) Die Bildung der Menschen (26) Abbildung: Prometheus bildet den Menschen; Prometheus raubt die ätherische Flamme; Pandora eröffnet die Büchse; Prometheus an den Felsen geschmiedet (-) Die Nacht und das Fatum, das über Götter und Menschen herrscht (37) Abbildung: Parzen (-) Die alten Götter (45) Amor (46) Die himmlische Venus (48) Aurora (49) Helios (49) Selene (51) Hekate (52) Oceanus (53) Die Oceaniden (54) Metis (55) Eurynome (55) Styr (55) Mnemosyne (57) Themis (57) Pontos (60) Nereus (61) Nereiden (61) Thaumas (63) Eurybia (64) Phorkys und die schöne Ceto oder die Erzeugung der Ungeheuer (64) Die Flüsse (66) Proteus (66) Cheiron (67) Atlas (67) Nemesis (68) Prometheus (68) Jupiter, der Vater der Götter (68) Die Eifersucht der Juno (71) Vesta (73) Ceres (74) Jupiter (74) Die neue Bildung des Menschengeschlechts (77) Ogyges (80) Inachus (80) Cekrops (82) Deukalion (82) Die alten Einwohner von Arkadien (84) Der Dodonische Wald (84) Die menschenähnliche Bildung der Götter (84) Jupiter (85) Abbildung: Jupiter (-) Juno (91) Abbildung: Juno (-) Apollo (95) Abbildung: Apollo (-) Neptun (101) Abbildung: Neptun (-) Minerva (106) Abbildung: Minerva (-) Mars (111) Abbildung: Mars (-) Venus (115) Diana (119) Abbildung: Diana, Ceres (-) Ceres (123) Vulkan (128) Vesta (134) Abbildung: Vukan (-) Abbildung: Vesta, Merkur (-) Merkur (137) Abbildung: Die Erde (-) Die Erde (145) Cybele (146) Bacchus (148) Abbildung: Bacchus, Silen (-) Die heiligen Wohnplätze der Götter unter den Menschen (159) Kreta (160) Dodona (161) Delos (163) Delphi (164) Argos (167) Olympia (168) Athen (170) Cypern (171) ?nidus (171) Kythira (172) Lemnos (172) Ephesos (172) Thracien (173) Arkadien (175) Phrygien (176) Das Götterähnliche Menschengeschlecht (178) Perseus (182) Bellerophon (189) Herkules (192) Die zwölf Arbeiten des Herkules (201) Der Nemeische Löwe (201) Die Lernäische Schlange (202) Der Erymanthische Eber (203) Der Hirsch der Diana (204) Die Stymphaliden (204) Das Wehrgehenk der Königin der Amazonen (205) Der Stall der Augias (206) Der Kretensische Stier (207) Die Rosse des Diomedes (208) Der dreiköpfigre Geryon (209) Die goldenen Äpfel der Hesperiden (210) Der Höllenhund Kerberus (211) Die Taten des Herkules, welche er nicht auf fremden Befehl vollführt hat (213) Die Befreiung der Hesione (213) Die Überwindung des Anteils, Busiris und Rakus (215) Die Befreiung der ??Alceste aus der Unterwelt (217) Die Befreiung des Prometheus von seinen Qualen (218) Die Ausrichtung der Säulen an der Meerenge zwischen Europa und Afrika (219) Die Vermählung des Herkules und seine Vergehung und Schwächen (221) Des Herkules letzte Duldung und seine Vergötterung [handschriftliche Ergänzung fehlender Seiten] ([225]) Kastor und Pollux (227) Abbildung: Kastor und Pollux (-) Jason (231) Die Fahrt der Argonauten (235) Abbildung: Jason und Medea, Jason (-) Meleagros (248) Die Kalydonische Jagd (249) Atalante (250) Minos (251) Daedalus (255) Theseus (258) Abbildung: Daedalus, Theseus (-) Die Wesen, welche das Band zwischen Göttern und Menschen knüpfen (271) Genien (271) Abbildung: Eine Muse, ein Liebesgott (-) Musen (273) Liebesgötter (279) Grazien (280) Abbildung: Drei Grazien, eine Hore (-) Horen (283) Nymphen (283) Satyr (285) Faunen (286) Pan (288) Sylvan (290) Abbildung: Göttergruppe mit Faun, Tanzender Faun (-) Penaten (291) Priapos (292) Komus (293) Hymen (293) Orpheus (294) Cheiron (294) Abbildung: Orpheus, Cheiron und Achilles (-) Aklepios (295) Abbildung: Äskulap, Hygieia (-) Hygieia (297) Die Lieblinge der Götter (297) Ganymed (298) Atys (300) Tithonos (301) Anchises (302) Adonis (303) Hyakinthus (305) Cyparissus (305) Leukothoe (306) Endymion (307) Acis (308) Peleus (308) Abbildung: Jupiter und Ganymed, Sturz des Phaeton (-) Die tragischen Dichtungen (310) Theben (312) Kadmos (312) Ödipus (316) Eteokles und Polyneikes (320) Der Thebanische Krieg (321) Die Pelopiden (327) Troja (334) Niobe (346) Abbildung: Paris, Achill (-) Kephalos und Prokris (347) Phaethon (348) Die Schattenwelt (349) Pluto (350) Furien (354) Abbildung: Pluto, Charon (-) Die Strafen der Verurteilten im Tartaros (355) Tantalos (355) Trion (357) Phlegyas (358) Die Danaiden (359) Sisyphos (359) Amor und Psyche (360) Abbildung: Sisyphos, Amor und Psyche (-) Startseite (365) Startseite ([I]) Farbinformation (-) Einband (-

Hasard et destin dans le Anton Reiser de Karl Philipp Moritz

International audienceThe distinction between literary chance and chance as experience (E. Köhler) allows the originality of Moritz's autobiographical novel to be disengaged. This study of the motif of chance in book II ofAnton Reiser shows the establishment of a narrative method characterized by repressing the literary treatment of chance and maintaining of chance as a category of lived experience. In this text, the fortunate and unfortunate chances do not found the literary necessity of an exemplary destiny, but are the occasion for throwing light on the double determination, exterior and interior, that affects the character's existence, an existence that is experienced under the sign of a radical contingency. It is in this first obscurity that psychological analysis operates, not to establish the horizon of Providence, but to disengage the general lessons of an existence, and to give to its hero, at this moment, the consistency of a novelistic character.La distinction entre les deux catégories du « hasard vécu » (erlebter Zufall) et du « hasard littéraire » (literarischer Zufall), empruntée à Erich Köhler, permet d'aborder l'étude du roman autobiographique de Karl Philipp Moritz, Anton Reiser, en faisant ressortir l'ambivalence d'un projet "romanesque" en un sens nouveau. On montre ici comment le recul de la figuration du hasard littéraire au profit de la figuration du hasard vécu exprime la remise en cause du roman traditionnel et la recherche de nouvelles formes permettant de saisir et de donner forme à la consistance de la vie intérieure

A Word of Caution

Background: Minimally invasive liver surgery (MILS) has a high variance in the type of resection and complexity, which has been underestimated in learning curve studies in the past. The aim of this work was to evaluate complexity-adjusted learning curves over time for laparoscopic liver resection (LLR) and robotic liver resection (RLR). Methods: Cumulative sum analysis (CUSUM) and complexity adjustment were performed using the Iwate score for LLR and RLR (n = 647). Lowest point of smoothed data was used to capture the cutoff of the increase in complexity. Data were collected retrospectively at the Department of Surgery of the Charité-Universitätsmedizin Berlin. Results: A total of 132 RLR and 514 LLR were performed. According to the complexity-adjusted CUSUM analysis, the initial learning phase was reached after 117 for LLR and 93 procedures for RLR, respectively. With increasing experience, the rate of (extended) right hemihepatectomy multiplied from 8.4% to 18.9% for LLR (P = 0.031) and from 21.6% to 58.3% for RLR (P 0.05). The complexity-adjusted CUSUM analysis demonstrated for blood transfusion, conversion, and operative time an increase during the learning phase (T1), while a steady state was reached in the following (T2). Conclusions: The learning phase for MILS after adjusting for complexity is about 4 times longer than assumed in previous studies, which should urge caution

Solid organ transplantation programs facing lack of empiric evidence in the COVID‐19 pandemic: A By‐proxy Society Recommendation Consensus approach

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a drastic impact on national health care systems. Given the overwhelming demand on facility capacity, the impact on all health care sectors has to be addressed. Solid organ transplantation represents a field with a high demand on staff, intensive care units, and follow-up facilities. The great therapeutic value of organ transplantation has to be weighed against mandatory constraints of health care capacities. In addition, the management of immunosuppressed recipients has to be reassessed during the ongoing coronavirus disease 2019 (COVID-19) pandemic. In addressing these crucial questions, transplant physicians are facing a total lack of scientific evidence. Therefore, the aim of this study was to offer an approach of consensus-based guidance, derived from individual information of 22 transplant societies. Key recommendations were extracted and the degree of consensus among different organizations was calculated. A high degree of consensus was found for temporarily suspending nonurgent transplant procedures and living donation programs. Systematic polymerase chain reaction-based testing of donors and recipients was broadly recommended. Additionally, more specific aspects (eg, screening of surgical explant teams and restricted use of marginal donor organs) were included in our analysis. This study offers a novel approach to informed guidance for health care management when a priori no scientific evidence is available

Hepatic artery reconstruction using an operating microscope in pediatric liver transplantation—Is it worth the effort?

Introduction: In pediatric liver transplantation (pLT), hepatic artery thrombosis (HAT) is associated with inferior transplant outcome. Hepatic artery reconstruction (HAR) using an operating microscope (OM) is considered to reduce the incidence of HAT. Methods: HAR using an OM was compared to a historic cohort using surgical loupes (SL) in pLT performed between 2009 and 2020. Primary endpoint was the occurrence of HAT. Secondary endpoints were 1-year patient and graft survival determined by Kaplan-Meier analysis and complications. Multivariate analysis was used to identify independent risk factors for HAT and adverse events. Results: A total of 79 pLTs were performed [30 (38.0%) living donations; 49 (62.0%) postmortem donations] divided into 23 (29.1%) segment 2/3, 32 (40.5%) left lobe, 4 (5.1%) extended right lobe, and 20 (25.3%) full-size grafts. One-year patient and graft survival were both 95.2% in the OM group versus 86.2% and 77.8% in the SL group (p = .276 and p = .077). HAT rate was 0% in the OM group versus 24.1% in the SL group (p = .013). One-year patient and graft survival were 64.3% and 35.7% in patient with HAT, compared to 93.9% and 92.8% in patients with no HAT (both p < .001). Multivariate analysis revealed HAR with SL (p = .022) and deceased donor liver transplantation (DDLT) (p = .014) as independent risk factors for HAT. The occurrence of HAT was independently associated with the need for retransplantation (p < .001) and biliary leakage (p = .045). Conclusion: In pLT, the use of an OM is significantly associated to reduce HAT rate, biliary complications, and graft loss and outweighs the disadvantages of delayed arterial perfusion and prolonged warm ischemia time (WIT)

Author Correction: Non-local effect of impurity states on the exchange coupling mechanism in magnetic topological insulators

A Correction to this paper has been published: https://doi.org/10.1038/s41535-021-00314-

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.

There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17-19 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF